2021 Webinar Series: Infrastructure to Facilitate Access to Advanced Therapies

24 June 2021, 3.30pm* - 5.00pm SGT

Via Zoom

*Corresponds to 3.30am Eastern Daylight Time (EDT), 9.30am Central European Summer Time (CEST) & 5.00pm Australian Central Standard Time (ACT)

Registration Fee: SGD$50 (inclusive of GST)

Registration is complimentary for ASEAN National Regulatory Authorities, Ministries of Health and SingHealth Duke-NUS Medical School Students and Staff,
please email us to register.

Recent innovations in medical care include the cell, tissue and gene therapies, which reflects the advances in clinical sciences and aligns to the new paradigm of precision medicine. While this holds the exciting potential to address rare diseases and conditions that have failed conventional treatments, the access to these health products can be hampered by regulatory and healthcare systems. In this webinar, various aspects of facilitating access to advanced therapies will be discussed, ranging from health system policies, manufacturing facilities, regulations, to healthcare professionals and industry. Join us and the panellists to hear the experiences in Singapore, and what we can expect next in this progressive domain.



Date and Time

24 Jun 2021 @ 15:30 - 24 Jun 2021 @ 17:00


Register now!


Speaker & Facilitator


Adj Asst Prof Srinivasan Kellathur

Advanced Therapy Products Branch
Health Products Regulation Group
Health Sciences Authority (HSA) Singapore
Adjunct Assistant Professor, CoRE


Danny Soon_CoRE

Adj Asst Prof Danny Soon

Chief Executive Officer
Consortium for Clinical Research and Innovation Singapore (CRIS)
Executive Director
Singapore Clinical Research Institute (SCRI)
Adjunct Assistant Professor, CoRE

Francesca Lim

Dr Francesca Lorraine Lim

Haematopoietic Stem Cell Transplant programme
SingHealth Duke-NUS Transplant Centre

Sudipto Bari

Dr Sudipto Bari

Senior Project Administrator
Advanced Cell Therapy and Research Institute Singapore (ACTRIS)
Senior Research Fellow & Principle Medical Laboratory Scientist
National Cancer Centre, Singapore

Wong Kum Cheun

Mr Wong Kum Cheun

Member of Asia Partnership Conference of Regenerative Medicine Associations (APACRM)
(representing the Singapore Association of Pharmaceutical Industries, SAPI)
Asia Pacific Regulatory & Development Policy, Novartis 
Visiting Expert, CoRE